Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Prospective Evaluation of the Clinical Profile and Treatment Outcomes of Proximal Humerus Fractures. (SPHEER)

10 augusti 2021 uppdaterad av: Bryan Tan, Tan Tock Seng Hospital

With an ageing population, fragility fractures secondary to osteoporosis are on a increasing trend. Proximal humerus fractures are common fractures which account for a significant proportion of these fragility fractures. They significantly affect patients function and independence particularly in the elderly.

Currently, treatment options range from conservative treatment with an arm sling to fixation either with plates or intramedullary devices to arthroplasty ranging from a hemiarthroplasty to the latest reverse shoulder arthroplasty. While is there has been a global trend towards surgical treatment for such fractures, there is significant controversy regarding the best treatment with many studies reporting disappointing functional outcomes including residual shoulder pain, limitation in shoulder motion and decreased quality of life regardless of treatment option selected.

In this day and age where healthcare cost is a big concern both at the individual patient level but at a government level as well, evaluating the cost effectiveness of treatment becomes essential as well. Currently in Singapore, there have been a significant trend of an increased use of surgical treatment of proximal humerus fractures however we have very little data in our local context not only to evaluate the clinical effectiveness but also the cost effectiveness of surgical treatment in comparison to conservative treatment.

The primary aim of the study is

  1. To understand the epidemiology and prognostic factors for proximal humerus fractures

    • Incidence
    • Health service utilization
    • clinical and functional outcomes
  2. To estimate the relative cost-effectiveness of surgical vs non-surgical treatment pathways for managing patients with proximal humerus fractures.

We hypothesize that surgical fixation of the proximal humerus is both clinically and cost effective

Studieöversikt

Status

Rekrytering

Studietyp

Observationell

Inskrivning (Förväntat)

400

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

      • Singapore, Singapore
        • Rekrytering
        • Tan Tock Seng Hospital
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

21 år till 110 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Sannolikhetsprov

Studera befolkning

Adults with proximal humerus fracture going for surgical or conservative treatment option

Beskrivning

Inclusion Criteria:

  1. Age 21 years old and above
  2. Radiologically confirmed proximal humerus fracture
  3. Within 3 weeks of their injury

Exclusion Criteria:

  1. Open fracture
  2. Mentally incompetent patients
  3. Co-morbidities precluding anaesthesia
  4. Severe soft tissue compromise
  5. Neurovascular compromise
  6. Pathological fracture other than osteoporosis
  7. Surgery delayed > 3 weeks
  8. Pregnancy

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Constant Shoulder Score - change over 6 weeks, 3, 6, 12 months
Tidsram: Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months

To evaluate the clinical outcomes over time by comparing the change in constant shoulder score over a period of 1 year. The Constant Shoulder Score is used to assess the level of pain and the patient's ability to carry out normal daily activities.

Constant score of the unaffected shoulder was also assessed at baseline to compare the function between the two shoulders.

Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
Oxford Shoulder Score - change over 6 weeks, 3, 6, 12 months
Tidsram: Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
A 12-item patient-report questionnaire developed to evaluate the outcome of shoulder surgery, excluding surgery for instability. The OSS contains two subscales, pain and activities of daily living. Each responses is of a 0-4 scoring format with a higher score representing better function. Hence, the highest possible total score is 48 and a higher score represents a better outcome.
Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
QuickDASH scoring - change over 6 weeks, 3, 6, 12 months
Tidsram: Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
This score is a subset of 11 items from the 30-item DASH and is a self-reported questionnaire in which the response options are presented as 5-point Likert scales. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability).
Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
EQ5D-5L - change over 6 weeks, 3, 6, 12 months
Tidsram: Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
EuroQol-5 Dimensions (EQ-5D) consists of 2 dimensions, the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by selecting the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS will be used as a quantitative measure of health outcome.
Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
Costing questionnaire
Tidsram: Assessed at 6 weeks, 3 months, 4.5 months, 6 months
Questionnaire measuring the direct and indirect costs
Assessed at 6 weeks, 3 months, 4.5 months, 6 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Bryan Tan, Tan Tock Seng Hospital

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

21 augusti 2017

Primärt slutförande (Förväntat)

31 december 2023

Avslutad studie (Förväntat)

31 december 2023

Studieregistreringsdatum

Först inskickad

10 augusti 2021

Först inskickad som uppfyllde QC-kriterierna

10 augusti 2021

Första postat (Faktisk)

13 augusti 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

13 augusti 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 augusti 2021

Senast verifierad

1 augusti 2021

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 2016/01241

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera